Search bioRxiv⌕ Search

Biology subjects

Oren, G.

Publications and source records attributed to Oren, G..

2 recordsLinked to original sources

Structure-aware Graph Learning Predicts RNA Editability Across Tissues and Species

Programmable A-to-I RNA editing using endogenous ADAR enzymes is emerging as a therapeutic strategy, but editability remains difficult to predict because ADAR recognition depends on double-stranded RNA geometry and stability rather than sequence alone. We present AdarEdit, a structure-explicit graph-attention framework that represents each dsRNA substrate as a nucleotide graph with backbone and base-pair edges. The framework includes a baseline model and a bio-aware model, with the latter augmenting this representation with typed interactions and a motif-sensitive sequence branch. We trained and evaluated both models on high-confidence inverted Alu duplexes (n = 884) with secondary structures predicted by RNAfold and editing levels measured across 8,603 GTEx RNA-seq samples spanning 47 tissues. Across five tissue contexts, the baseline and bio-aware models achieved strong held-out performance (test F1 = 0.814-0.869, AUROC = 0.869-0.933) and outperformed a matched structure-string baseline on the Liver split. The same graph representation retained predictive ability in evolutionarily distant non-Alu species (sea urchin, acorn worm, and octopus), suggesting conserved principles of ADAR substrate recognition. Finally, attention profiles and in silico mutagenesis recapitulated known biochemical constraints, including suppression by an upstream guanosine, and revealed longer-range asymmetric structural influences on editing. Because Alu duplexes are edited predominantly by ADAR1, AdarEdit is geared primarily to the ADAR1 regime. ADAR1 is particularly relevant to therapeutic editing given its broad tissue expression. The sources of this work are available at our repository: https://github.com/Scientific-Computing-Lab/AdarEdit

bioinformatics↗

Glutathione Peroxidase 8 (GPX8)-IL6 axis is essential in maintaining breast cancer mesenchymal stem-like state and aggressive phenotype

Metabolic reprogramming as a downstream result of oncogenic signaling pathways has been described as a hallmark of cancer. Here, we describe a reverse scenario in which a metabolic enzyme regulates cancer cell behavior by triggering a signaling pathway. We find that glutathione peroxidase 8 (GPX8), a poorly characterized redox enzyme that resides in the endoplasmic reticulum, is upregulated during the epithelial-to-mesenchymal (EMT) program in HMLE and A549 cells. In cancer patients, high tumor levels of GPX8 correlate with mesenchymal markers and poor patient outcome. Strikingly, GPX8 knockout in mesenchymal-like cells results in an epithelial-like morphology, downregulation of EMT characteristics, loss of cancer stemness features, and impeded tumor initiation in mice. We determine the mechanism governing this reduction in cancer aggressiveness is through the repression of crucial autocrine factors, in particular, interleukin-6 (IL-6). Specifically, GPX8 knockout impairs IL-6-driven activation of the JAK-STAT3 signaling pathway, a critical regulator of a cancer-aggressive state. Altogether, we uncover the GPX8-IL-6 axis as a novel metabolic-inflammatory pathway that acts as a robust EMT activator and program to induce aggressive cancer cell characteristics.

cancer biology↗